Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Cancers|March 11, 2023
Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?Vassili Anastay, Michael Baboudjian, Alexandra Masson-Lecomte, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Upper urinary tract urothelial cancer (UTUC)Mathieu Roumiguié, Thomas Seisen, Alexandra Masson-Lecomte, et al.
The French Journal of Urology|November 24, 2024
French AFU Cancer Committee Guidelines - Update 2024-2026: Non-muscle invasive bladder cancer (NMIBC)Mathieu Roumiguié, Priscilla Leon, Evanguelos Xylinas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2023
Transcriptomic Profiling of Upper Tract Urothelial Carcinoma: Bladder Cancer Consensus Classification Relevance, Molecular Heterogeneity, and Differential Immune SignaturesJacqueline Fontugne, Evanguelos Xylinas, Clémentine Krucker, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2025
Development and Validation of a Questionnaire Measuring Treatment Burden in Pediatric AsthmaSophie Schmartz, Pierrick Cros, Camille Cisterne, et al.
BJU International|May 30, 2024
A collaborative review of the microsatellite instability/deficient mismatch repair phenotype in patients with upper tract urothelial carcinomaPierre-Etienne Gabriel, Géraldine Cancel-Tassin, François Audenet, et al.
World Journal of Urology|February 22, 2023
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failureGéraldine Pignot, Michael Baboudjian, Cédric Lebacle, et al.
World Journal of Urology|August 9, 2023
Safety and efficacy of preoperative chemotherapy for muscle-invasive bladder cancer in elderly patientsClément Dumont, Amélie Aregui, Mathilde Hauchecorne, et al.
Pageof 12